Background Among patients with atrial fibrillation, the risk of stroke is highest for those with a
history of stroke; however, oral anticoagulants can lower the risk of recurrent stroke by two …

Survivors of stroke and transient ischaemic attacks are at risk of a recurrent stroke, which is
often more severe and disabling than the index event. Optimum secondary prevention of …

Abstract The Canadian Cardiovascular Society (CCS) atrial fibrillation (AF) guidelines
program was developed to aid clinicians in the management of these complex patients, as …

Komisję ESC ds. Wytycznych Postępowania nadzoruje i koordynuje przygotowywanie
nowych wytycznych i stanowisk przez grupy robocze i inne grupy ekspertów. Komitet jest …

Члены Рабочей группы подтвердили отсутствие финансовой поддержки/конфликта
интересов. В случае сообщения о наличии конфликта интересов, член (ы) Рабочей …

clinical guidelines, atrial fibrillation, ischemic stroke, anticoagulant therapy, vitamin K
antagonists, direct oral anticoagulants, triple antiplatelet therapy, rhythm control, electrical …

The choice of oral anticoagulant (OAC) for patients with atrial fibrillation (AF) may be
influenced by individual clinical features or by patterns of risk factors and comorbidities. We …

Objectives The aim was to perform a review of the efficacy and safety of new oral
anticoagulants (NOAs) in the management of venous thromboembolism (VTE). Methods …

Background No pooled analysis has been undertaken to assess the efficacy and safety of
the non‐vitamin K antagonist oral anticoagulants (NOACs) compared with warfarin in the …

Background: The “1-3-6-12-day rule” for starting direct oral anticoagulants (DOACs) in
patients with nonvalvular atrial fibrillation after acute ischemic stroke or transient ischemic …